Evidence map›Paper›PMID 18925930›Full record

ArticleCritical care (London, England)2008

Induction of Bim and Bid gene expression during accelerated apoptosis in severe sepsis.

Stefan U Weber, Jens-Christian Schewe, Lutz E Lehmann, Stefan Müller, Malte Book, Sven Klaschik, Andreas Hoeft, Frank Stüber

Open access · goldAbstract readComparative Study
In one paragraph

Article in Critical care (London, England), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 80 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Lymphopenia in sepsis: a narrative review.Critical care (London, England) · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Is lymphopenia different between SARS and COVID-19 patients?FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Review
  13. Review
  14. Immune Intervention in Sepsis.Frontiers in pharmacology · 2021
    Review
  15. Role of the adaptive immune response in sepsis.Intensive care medicine experimental · 2020
    Review
  16. Review
  17. Article
  18. Sustained high serum caspase-3 concentrations and mortality in septic patients.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2018
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Stefan U WeberDepartment of Anesthesiology and Intensive Care Medicine, University Bonn Medical Center, Sigmund-Freud-Strasse 25, 53129 Bonn, Germany. Stefan.weber@ukb.uni-bonn.de
Jens-Christian Schewe
Lutz E Lehmann
Stefan Müller
Malte Book
Sven Klaschik
Andreas Hoeft
Frank Stüber
University of Bonn · DECenter for Biologics Evaluation and Research · USUniversity Hospital Bonn · DEUniversity Hospital of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn transgenic animal models of sepsis, members of the Bcl-2 family of proteins regulate lymphocyte apoptosis and survival of sepsis. This study investigates the gene regulation of pro-apoptotic and anti-apoptotic members of the Bcl-2 family of proteins in patients with early stage severe sepsis.

methodsIn this prospective case-control study, patients were recruited from three intensive care units (ICUs) in a university hospital. Sixteen patients were enrolled when they fulfilled the criteria of severe sepsis. Ten critically ill but non-septic patients and 11 healthy volunteers served as controls. Blood samples were immediately obtained at inclusion. To confirm the presence of accelerated apoptosis in the patient groups, caspase-3 activation and phosphatidylserine externalisation in CD4+, CD8+ and CD19+ lymphocyte subsets were assessed using flow cytometry. Specific mRNAs of Bcl-2 family members were quantified from whole blood by real-time PCR. To test for statistical significance, Kruskal-Wallis testing with Dunn's multiple comparison test for post hoc analysis was performed.

resultsIn all lymphocyte populations caspase-3 (p < 0.05) was activated, which was reflected in an increased phosphatidylserine externalisation (p < 0.05). Accordingly, lymphocyte counts were decreased in early severe sepsis. In CD4+ T-cells (p < 0.05) and B-cells (p < 0.001) the Bcl-2 protein was decreased in severe sepsis. Gene expression of the BH3-only Bim was massively upregulated as compared with critically ill patients (p < 0.001) and 51.6-fold as compared with healthy controls (p < 0.05). Bid was increased 12.9-fold compared with critically ill patients (p < 0.001). In the group of mitochondrial apoptosis inducers, Bak was upregulated 5.6-fold, while the expression of Bax showed no significant variations. By contrast, the pro-survival members Bcl-2 and Bcl-xl were both downregulated in severe sepsis (p < 0.001 and p < 0.05, respectively).

conclusionsIn early severe sepsis a gene expression pattern with induction of the pro-apoptotic Bcl-2 family members Bim, Bid and Bak and a downregulation of the anti-apoptotic Bcl-2 and Bcl-xl proteins was observed in peripheral blood. This constellation may affect cellular susceptibility to apoptosis and complex immune dysfunction in sepsis.

Indexed as

ApoptosisAdultAgedApoptosis Regulatory ProteinsBcl-2-Like Protein 11BH3 Interacting Domain Death Agonist ProteinCase-Control StudiesFemaleGene Expression RegulationHumansMaleMembrane ProteinsMiddle AgedProspective StudiesProto-Oncogene ProteinsSepsisApoptosis Regulatory ProteinsBCL2L11 protein, humanBcl-2-Like Protein 11BH3 Interacting Domain Death Agonist ProteinBID protein, humanMembrane ProteinsProto-Oncogene Proteins

Identifiers

PMID18925930
PMCPMC2592767
OpenAlexW2095797199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.